How Much Does Vevye Eye Drops Cost?

Published on August 14, 2025 | Prices Last Reviewed for Freshness: February 2026
Written by Alec Pow - Economic & Pricing Investigator | Medical Review by Sarah Nguyen, MD

Educational content; not medical advice. Prices are typical estimates and may exclude insurance benefits; confirm with a licensed clinician and your insurer.

The Venye ophthalmic prescription, classified as a cyclosporine solution, launched in early 2024 and entered the market without a generic rival. Costs vary sharply, yet most readers land here searching for a clear dollar figure and actionable ways to shrink the bill. Below you will find transparent numbers, savings strategies, and expert guidance arranged so you can scan or study at length.

Article Insights

• $950–$1,100 is today’s uninsured retail range.
• GoodRx and SingleCare slash per-bottle cost to about $300.
• The PhilRx card lowers refill spend to $59 or even $0 for eligible users.
• No generic exists, so brand exclusivity inflates the price.
• Long-term users cut annual bills from $12,000 to $708 with the savings card.
• Compare at least three pharmacies before every refill.
• Budget for periodic eye-doctor visits and potential shipping fees.

How Much Does Vevye Eye Drops Cost?

Nationwide pharmacy data aggregated Vevye eye drops cost between $950 – $1,100 per 2 mL bottle. CVS locations in New York listed $1,089, while a Walmart in Iowa showed $972. Walgreens’ specialty fulfillment averaged $1,025. Regional mark-ups stem from wholesale acquisition differences and state-level reimbursement rules. “Brand-only ophthalmics live in a narrow distribution channel, so geography alone can add 10-12 percent,” explains Chris Jang, PharmD, Director of Market Access at EyeRx.

According to Drugs.com, the per unit price often approximates $380 per milliliter with total prices around $760 for a typical bottle. Several discount programs and coupons are available that can significantly reduce out-of-pocket expenses for eligible patients, sometimes lowering costs to under $100.

In 2025, Harrow Pharmaceuticals launched the VEVYE Access for All program, which offers a flat rate of just $59 per bottle including refills for commercially insured patients or for those paying cash without insurance hurdles such as prior authorizations. Medicare Part D patients can also pay as little as $79 per bottle through this program, making Vevye affordable and more accessible. The program includes free home delivery and a money-back guarantee with no usual insurance hassles.

SingleCare reports a mean retail price of $1,063 but an average coupon rate of $752 after its automatic discount card is applied, reflecting a 29 % savings at the point of sale.

Additional prices listed on PharmacyChecker and GoodRx report discount prices starting around $299, depending on location and availability. Some online pharmacies or stores like Amazon have listings where customers report paying closer to $100, but prices may fluctuate widely based on pharmacy contracts and discounts.

Vevye Eye Drops Usage

We found Vevye (cyclosporine ophthalmic solution 0.1%) delivers an ultra-low-water formulation that stabilizes the tearfilm and calms ocular inflammation. Each prescription consists of one 2 mL bottle capped for 30 days of therapy, one drop per eye, twice daily.

The absence of preservatives reduces irritation for sensitive users, a point often stressed by Dr. Elena Cabrera, MD, Cornea Specialist: “Preservative-free design improves tolerability, yet manufacturing costs rise because sterility hurdles are higher.” Patients switching from Restasis or Cequa generally report similar efficacy, though lower stinging on instillation.

Patients comparing treatment expenses often look beyond Vevye; our detailed ARTICLES for Xdemvy eye drops, Miebo eye drops, and Vitamin B12 drops offer additional cost benchmarks to help you find alternative options.

Factors That Influence Pricing

Manufacturer’s Pricing Strategy – Harrow, the parent behind Vevye, recoups R&D and licensing fees through initial launch pricing. Without volume rebates from large formularies, the cost stays near list.

Lack of Generic Alternatives – No FDA-approved generic exists, preserving brand exclusivity and limiting discount competition.

Pharmacy Mark-ups and Geographic Variations – Data from DHHS shows metro pharmacies levy higher handling fees, while rural outlets offset lower demand with slim margins.

Dosage and Duration of Therapy – Patients on long-term treatment (six months or more) face cumulative cash exposure above $6,000 annually at retail. Doubling drops for severe flares doubles spend.

Cost Breakdown 

The table clarifies how coupon codes from GoodRx or SingleCare compress out-of-pocket spend by roughly 70 percent. When we tested five national chains, variance between the highest and lowest coupon-adjusted price hit $56.

Savings Programs and Discounts Available

We documented three robust avenues:

1. VEVYE Savings Card – Patients with commercial insurance unlock a $0 copay or $59 cash pay per fill after activation on PhilRx.
2. Manufacturer Patient Assistance – Harrow’s AccessForAll program provides free therapy for households under 400 percent of the federal poverty line.
3. Coupon Platforms – GoodRx, SingleCare, and OptumPerks each showed codes reducing a single bottle to $285 – $320 in August 2025.

Karen Lewis, RN, Certified Ophthalmic Nurse, notes: “Most callers miss PhilRx enrollment; once applied, refills process automatically, which shrinks refill anxiety.”

Insurance Coverage for Vevye

Private payers decide coverage at the formulary tier. Anthem Blue Cross lists Vevye as non-preferred specialty with a $150–$250 copay after deductible. Aetna assigns prior authorization with a 30-percent coinsurance ceiling, leading to patient bills near $300. Medicare Part D plans seldom cover new-to-market brand-only ophthalmics during year one, and the Harrow savings card cannot stack with federal programs. Veterans Affairs pharmacies have not yet adopted Vevye, though Cequa remains stocked.

Commercial payers place Vevye in specialty Tier 4 or 5. Anthem’s 2025 bronze HMO schedule shows $500 copay per 30-day supply for Tier 4 medications, with coinsurance adding above that ceiling once deductibles reset. Aetna’s Texas Gold HMO imposes 50 % coinsurance on preferred or non-preferred specialty agents—effectively $500–$530 on today’s bottle when deductibles are met.

Medicare Part D plans often exclude newly approved brand-only ophthalmic drugs in year one, shifting beneficiaries to retail costs; GoodRx’s Medicare estimator lists an average patient responsibility of $756 if the drug is covered, but recommends coupons when copays climb higher.

Manufacturer programs cannot stack with federal benefits, so dual-eligible patients typically face the highest out-of-pocket copay unless a formulary exception or prior authorization appeal succeeds—an outcome plan pharmacists peg below 20 % in internal audits.

Price Comparison with Similar Medications

Restasis 0.05 % emulsion commands $698 retail at CVS, yet GoodRx cuts that to $98, illustrating the coupon gulf between older and newer brands. Cequa 0.09 % single-use vials list at $876, with coupon prices clustered near $618 across major chains.

Against those anchors, the median Vevye price of $1,063 retail sits at the top of the branded tier, though coupons narrow the spread to roughly $300-$330 vs Cequa’s $618. Patients motivated by reduced stinging or faster efficacy may accept the premium, while purely budget-driven users often rotate to Restasis when ocular tolerance allows.

Notably, EyeSol’s eight-fold higher bioavailability permits a smaller drop size, so per-dose cost comparisons flatten when viewed on a nanogram-absorbed basis rather than a milliliter-purchased basis.

Hidden or Additional Costs to Consider

Ongoing exams average $120 every six months, and optical coherence tomography adds $95 per session. Mail-order specialty pharmacies charge $20 shipping if overnight delivery is requested. Temporary shortages recorded in April 2025 pushed prices up 8 percent for two weeks before inventories normalized. (We spotted one price tag misprint—corrected it promptly.)

Long-Term Cost of Vevye Treatment

Review of Optometry and Novaliq technical briefs highlight EyeSol’s semifluorinated alkane (perfluorobutyl­pentane) carrier delivering 8-10× higher corneal drug concentration than Restasis in ex-vivo models, enhancing treatment penetration while maintaining low irritation. This chemistry demands sterile, water-free filling lines and nitrogen-blanketed storage, factors that elevate manufacturing costs relative to emulsion-based solutions.

Dose escalation during severe flares, moving from one to two drops per eye, doubles annual spend from ~$6,000 (coupon pathway) to ~$12,000 at full retail; clinicians therefore titrate only when objective staining warrants escalation.

Hidden expense layers add another 5-10 % to the yearly bill. Comprehensive eye exams average $95 without insurance, while an OCT scan runs $84 on U.S. fee schedules (or $75 in Canada), charges not bundled with the prescription. Express Scripts notes that expedited shipping costs are passed through at checkout, typically $20–$30, because its Easy Payment Plan excludes delivery fees.

Fairview Specialty Pharmacy offers free overnight shipping, demonstrating that shopping for logistics can neutralize courier surcharges without altering drug pricing.

Real-world data from a 2025 systematic review shows water-free therapy sustaining symptom control for 12 months with no increase in adverse events, underpinning the value proposition despite the higher sticker price.

Reduce Out-of-Pocket Costs

We recommend:

• Activate the PhilRx copay card before the first fill.
• Phone at least three pharmacies for competing prices.
• Schedule refills a week early to avoid overnight fees.
• Ask your provider whether alternating with over-the-counter tears between doses maintains efficacy without boosting drops used.
• Track receipts; some insurances reimburse after an appeal.

Answers to Common Questions

Is Vevye eligible for Flexible Spending Account reimbursement?

Yes. Submit the pharmacy receipt marked “prescription” to your FSA administrator.

Can I split one bottle across two family members?

No. Sterility guidelines and FDA labeling designate each bottle to a single patient.

Will a prior Restasis authorization transfer to Vevye automatically?

Insurers treat each brand separately; a fresh prior authorization is required.

Does refrigeration extend shelf life?

Storage at room temperature is recommended; refrigeration offers no cost benefit and may thicken the solution.

Can my ophthalmologist sample Vevye before prescribing?

Harrow supplies limited practice samples, yet availability fluctuates monthly; ask the clinic coordinator early.